Patent Assignment
Reel/Frame 058615/0518
Assignment of Assignor's Interest
Recorded: 2022-01-11
Pages: 9
Assignee
SHIRE HUMAN GENETIC THERAPIES, INC.
300 SHIRE WAY, LEXINGTON, MASSACHUSETTS, 02421
Covered Property
(1)
Heteroaryl Plasma Kallikrein Inhibitors
Patent:
11,370,803 →
Application:
17/024,189 →
Publication:
US 2021/0079022
PCT:
PCT/US2020/051249 ↗
Related Assignments
(8)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Mar 30, 2021
From: SHIRE HUMAN GENETIC THERAPIES, INC.
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 055766/0572 →
Assignment of Assignor's Interest
Jan 11, 2022
From: ELLARD, JOHN MARK; RAE, ALASTAIR
To: CHARLES RIVER DISCOVERY RESEARCH SERVICES UK LIMITED
Reel/Frame 058615/0568 →
Assignment of Assignor's Interest
Jan 11, 2022
From: BIODURO LLC
To: SHIRE HUMAN GENETIC THERAPIES, INC.
Reel/Frame 058615/0594 →
Assignment of Assignor's Interest
Jan 11, 2022
From: CHARLES RIVER LABORATORIES, INC.; CHARLES RIVER DISCOVERY RESEARCH SERVICES UK LIMITED
To: SHIRE HUMAN GENETIC THERAPIES, INC.
Reel/Frame 058615/0610 →
Assignment of Assignor's Interest
Jan 11, 2022
From: FINK, SARAH JOCELYN
To: BIODURO LLC
Reel/Frame 058615/0986 →
Assignment of Assignor's Interest
Feb 22, 2022
From: CHARLES RIVER DISCOVERY RESEARCH SERVICES UK LIMITED
To: CHARLES RIVER LABORATORIES, INC.
Reel/Frame 059065/0887 →
Assignment of Assignor's Interest
Mar 7, 2022
From: SHIRE HUMAN GENETIC THERAPIES, INC.
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 059185/0504 →
Assignment of Assignor's Interest
Aug 18, 2022
From: CHARLES RIVER LABORATORIES, INC.
To: SHIRE HUMAN GENETIC THERAPIES, INC.
Reel/Frame 060842/0547 →